Advanced Biomed is trading at $3.42, with a -9.04% change on October 22, 2026, amid broader risk-off pressure; no new company-specific announcement was identified.
- Reuters reported U.S. stocks opened lower as renewed AI-spending concerns and rising oil prices weighed on markets. Supplied data shows the Nasdaq down 2.23% and the S&P 500 down 1.27%.
- The October 13 full-year results do not establish a fresh catalyst.